There is a concordance regarding the role of APRIL in this malignancy, suggesting that this cytokine can actually promote the survival, proliferation, and migration of breast cancer cells (149–152) in accordance with the pro-proliferative action of APRIL in epithelial tumors and hematological malignancies (79). This evidence concerns the gene TNFSF13 and breast carcinoma.